The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 31, 2023

Filed:

May. 22, 2020
Applicant:

Progeneron, Llc, Aliso Viejo, CA (US);

Inventors:

David Scharp, Aliso Viejo, CA (US);

Mukhtar Siddiqui, San Ramon, CA (US);

Jennifer Aguas Hurtikant, Downey, CA (US);

David Bondurant, San Clemente, CA (US);

Brian Haight, Yorba Linda, CA (US);

Assignee:

Progeneron, LLC, Aliso Viejo, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/23 (2006.01); A61Q 19/08 (2006.01); A61K 9/107 (2006.01); A61K 31/015 (2006.01); A61K 47/42 (2017.01); A61K 36/28 (2006.01); A61K 31/25 (2006.01); A61K 36/185 (2006.01); A61K 31/201 (2006.01); A61K 31/05 (2006.01); A61K 31/455 (2006.01); A61K 47/14 (2017.01); A61K 36/886 (2006.01); A61K 47/26 (2006.01); A61K 33/06 (2006.01); A61K 8/9794 (2017.01); A61K 8/9789 (2017.01); A61K 8/31 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 36/23 (2013.01); A61K 8/31 (2013.01); A61K 8/9789 (2017.08); A61K 8/9794 (2017.08); A61K 9/0014 (2013.01); A61K 9/107 (2013.01); A61K 31/015 (2013.01); A61K 31/05 (2013.01); A61K 31/201 (2013.01); A61K 31/25 (2013.01); A61K 31/455 (2013.01); A61K 33/06 (2013.01); A61K 36/185 (2013.01); A61K 36/28 (2013.01); A61K 36/886 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); A61K 47/42 (2013.01); A61Q 19/08 (2013.01);
Abstract

Compositions for the treatment of some orphan diseases and oral mucosal ulcers, many with similarities in terms of their anti-inflammatory and anti-oxidative activities, but also multiple differences in their observed abilities that can be combined to challenge the current, underlying pathophysiology. The orphan diseases of interest are Dupuytren's Contracture, Peyronie's Disease, Scleroderma, Raynaud's (or Renaud's) Phenomenon, chemotherapy/radiation induced oral mucosal ulceration, and aphthous ulcers; and more frequent skin issues of skin damage from cuts, abrasions, and burns; aging skin changes, and toe nail fungus. These can be treated with the disclosed compositions with the proper combination and alteration of ingredients inclusive of alpha-pinene, an aloe vera preparation, and a shea butter preparation. A process for preparation of such ingredients in a water-in-oil emulsion is described herein.


Find Patent Forward Citations

Loading…